These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 26984154)
1. Chronic fatigue syndrome in the psychiatric practice. Van Duyse A; Mariman A; Poppe C; Michielsen W; Rubens R Acta Neuropsychiatr; 2002 Jun; 14(3):127-33. PubMed ID: 26984154 [TBL] [Abstract][Full Text] [Related]
2. [Chronic fatigue syndrome: psychiatric perspectives]. Youssefi M; Linkowski P Rev Med Brux; 2002 Sep; 23(4):A299-304. PubMed ID: 12422451 [TBL] [Abstract][Full Text] [Related]
3. Cognitions, behaviours and co-morbid psychiatric diagnoses in patients with chronic fatigue syndrome. Cella M; White PD; Sharpe M; Chalder T Psychol Med; 2013 Feb; 43(2):375-80. PubMed ID: 22571806 [TBL] [Abstract][Full Text] [Related]
4. Psychiatric comorbidity in persons with chronic fatigue syndrome identified from the Georgia population. Nater UM; Lin JM; Maloney EM; Jones JF; Tian H; Boneva RS; Raison CL; Reeves WC; Heim C Psychosom Med; 2009 Jun; 71(5):557-65. PubMed ID: 19414619 [TBL] [Abstract][Full Text] [Related]
5. An overview of chronic fatigue syndrome. Krupp LB; Mendelson WB; Friedman R J Clin Psychiatry; 1991 Oct; 52(10):403-10. PubMed ID: 1938975 [TBL] [Abstract][Full Text] [Related]
6. Depression and somatization in the chronic fatigue syndrome. Lane TJ; Manu P; Matthews DA Am J Med; 1991 Oct; 91(4):335-44. PubMed ID: 1951377 [TBL] [Abstract][Full Text] [Related]
7. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. Buchwald D; Pearlman T; Umali J; Schmaling K; Katon W Am J Med; 1996 Oct; 101(4):364-70. PubMed ID: 8873506 [TBL] [Abstract][Full Text] [Related]
8. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome. Di Giorgio A; Hudson M; Jerjes W; Cleare AJ Psychosom Med; 2005; 67(3):433-40. PubMed ID: 15911907 [TBL] [Abstract][Full Text] [Related]
9. The neuroendocrinology of chronic fatigue syndrome. Cleare AJ Endocr Rev; 2003 Apr; 24(2):236-52. PubMed ID: 12700181 [TBL] [Abstract][Full Text] [Related]
10. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome. Gaab J; Engert V; Heitz V; Schad T; Schürmeyer TH; Ehlert U J Psychosom Res; 2004 Apr; 56(4):419-24. PubMed ID: 15094026 [TBL] [Abstract][Full Text] [Related]
11. Shilajit attenuates behavioral symptoms of chronic fatigue syndrome by modulating the hypothalamic-pituitary-adrenal axis and mitochondrial bioenergetics in rats. Surapaneni DK; Adapa SR; Preeti K; Teja GR; Veeraragavan M; Krishnamurthy S J Ethnopharmacol; 2012 Aug; 143(1):91-9. PubMed ID: 22771318 [TBL] [Abstract][Full Text] [Related]
12. Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system? Van Houdenhove B; Van Den Eede F; Luyten P Med Hypotheses; 2009 Jun; 72(6):701-5. PubMed ID: 19237251 [TBL] [Abstract][Full Text] [Related]
13. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS. Twisk FN; Maes M Neuro Endocrinol Lett; 2009; 30(3):284-99. PubMed ID: 19855350 [TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids and glucocorticoid receptors: mediators of fatigue? Cleare AJ Acta Neuropsychiatr; 2003 Dec; 15(6):341-53. PubMed ID: 26983770 [TBL] [Abstract][Full Text] [Related]